Silji Abraham - 01 Mar 2023 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role: SVP, Chief Technology Officer
Signature: Ryan Metz, as agent for Silji Abraham
Issuer symbol: WST
Transactions as of: 01 Mar 2023
Net transactions value: -$409,373
Form type: 4
Filing time: 22 Mar 2023, 16:41:52 UTC
Previous filing: 23 Feb 2023
Next filing: 02 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WST	Common Stock	Award	$74,478	+234	+4.3%	$318.28	5,709	01 Mar 2023	Direct	F1
transaction	WST	Common Stock	Sale	$483,850	-1,500	-26%	$322.57	4,209	09 Mar 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vesting of Bonus & Incentive Grant
F2	The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $322.50 to $323.00, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.

Content

Vesting of Bonus & Incentive Grant

The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $322.50 to $323.00, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.